It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1984.
1984 | Mumbai, Maharashtra, India | ActiveSynex Pharmaceuticals Pvt Ltd, a active private limited company, was established on 07 April 1984 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239MH1984PTC032614. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Hemant Gandhi (Director), Hetal Jay Sanghavi (Director). It holds ₹1.60 M open charges and ₹1.38 Cr settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at 95/96, Abcd Government Industrial Estate Charkop, Kandivali (West), Mumbai, Maharashtra, 400067.
U24239MH1984PTC032614
032614
07 April 1984
₹2.50 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Synex Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemant Gandhi | Director | 07 Apr 1984 | Current |
| Hetal Jay Sanghavi | Director | 02 Jul 2003 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synex Pharmaceuticals Pvt Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 80.64% increase in profit. The company's net worth dipped by a decrease of 0.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Synex Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,600,000.00
₹13,836,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 1995 | State Bank Of India | ₹0.20 M | Open |
| 14 Feb 1985 | The Maharashtra Staet Financial Corp. | ₹1.40 M | Open |
| 05 Apr 1999 | State Bank Of India | ₹7.50 M | Satisfied |
| 06 Mar 1998 | State Bank Of India | ₹2.94 M | Satisfied |
| 06 Mar 1998 | State Bank Of India | ₹2.20 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Synex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Synex Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Progress on Synex Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was documented.
Progress on A charge registered on 05 Apr 1999 via Charge ID 90210973 with State Bank Of India was fully satisfied on 17 Nov 2006. was documented.
Progress on A charge registered on 06 Mar 1998 via Charge ID 90210945 with State Bank Of India was fully satisfied on 17 Nov 2006. was documented.
A charge registered on 06 Mar 1998 via Charge ID 90213148 with State Bank Of India was fully satisfied on 17 Nov 2006. was recorded as a recent event.
The activity A charge registered on 18 Oct 1996 via Charge ID 90212942 with State Bank Of India was fully satisfied on 17 Nov 2006. was completed.
The CIN of Synex Pharmaceuticals Pvt Ltd is U24239MH1984PTC032614.
Synex Pharmaceuticals Pvt Ltd is headquartered at 95/96, Abcd Government Industrial Estate Charkop, Kandivali (West), Mumbai, Maharashtra, 400067.
Synex Pharmaceuticals Pvt Ltd was incorporated on 07 April 1984.
The current directors of Synex Pharmaceuticals Pvt Ltd are
The primary industry of Synex Pharmaceuticals Pvt Ltd is Pharma.
Synex Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Synex Pharmaceuticals Pvt Ltd is ₹2.50 M, and the paid-up capital is ₹1.00 M.
The compliance status of Synex Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX